Janssen Research & Development, LLC — Federal Contractor Profile
JANSSEN RESEARCH & DEVELOPMENT, LLC: $509.4M in Federal Contracts for Pharmaceutical Research
Contractor Overview
Total Contract Value: $509,393,777 ($509.4M)
Total Awards: 9
Company Profile
JANSSEN RESEARCH & DEVELOPMENT, LLC is a significant player in the federal contracting landscape, with a total contract value of $509.4 million over 9 contracts. The company specializes in pharmaceutical research and development, with a focus on biologics, vaccines, and therapeutics. Their core capabilities include clinical research, drug development, and regulatory affairs. While the company has not won any recent contracts, their historical performance and track record suggest a strong presence in the federal market. The nature of their government business is primarily research and development, which is critical for advancing medical treatments and public health initiatives. The company's contract patterns reveal a reliance on a few key agencies, indicating a high level of dependency. However, their consistent performance and diverse range of services suggest a robust and adaptable business strategy. Compared to industry peers, JANSSEN RESEARCH & DEVELOPMENT, LLC holds a dominant position in the pharmaceutical research sector, leveraging its extensive expertise and resources to secure contracts. The company's outlook is stable, with a focus on expanding its research capabilities and maintaining its strong relationships with federal agencies.
Specializations
- Pharmaceutical Research
- Biologics Development
- Vaccine Research
- Therapeutics Development
- Regulatory Affairs
- Clinical Research
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts were sole-source)
Agency Concentration: high
Growth Trajectory: stable
Sole Source Rate: 100%
Recompete Rate: 0% (no recompete/renewal contracts)
Competitive Position
JANSSEN RESEARCH & DEVELOPMENT, LLC holds a dominant position in the pharmaceutical research sector. The company's extensive expertise and resources allow it to secure significant contracts, primarily through sole-source awards. This indicates a strong market position and the ability to meet the unique needs of federal agencies in the field of medical research and development.
Value to Taxpayers
JANSSEN RESEARCH & DEVELOPMENT, LLC provides critical value to taxpayers through its specialized research and development services. The company's focus on biologics, vaccines, and therapeutics is essential for advancing medical treatments and public health initiatives. However, the sole-source nature of their contracts raises concerns about competition and potential cost escalations. The company's consistent performance and diverse range of services suggest a robust and adaptable business strategy, which is beneficial for the federal government.
Agency Relationships
JANSSEN RESEARCH & DEVELOPMENT, LLC has a high level of dependency on a few key agencies, indicating a concentrated client base. This concentration could pose risks if there are changes in agency priorities or funding. The company's strong relationships with these agencies are crucial for maintaining its federal business, but there is a potential for dependency risks.
Red Flags
- 100% sole-source contracts: This indicates a lack of competition, which could lead to higher costs and reduced innovation.
- High agency concentration: The company's reliance on a few key agencies poses dependency risks and could limit its ability to diversify its client base.
- No recent contracts: The absence of recent contracts suggests potential challenges in securing new business, which could impact the company's growth trajectory.
Green Flags
- Diverse range of services: JANSSEN RESEARCH & DEVELOPMENT, LLC offers a wide range of research and development services, which is beneficial for the federal government.
- Consistent performance: The company has a strong track record of delivering on its contracts, which is a positive indicator of reliability.
- Extensive expertise: The company's specialized knowledge in biologics, vaccines, and therapeutics is critical for advancing medical treatments and public health initiatives.
Key Contracts
JANSSEN RESEARCH & DEVELOPMENT, LLC has secured significant contracts with the federal government, totaling $509.4 million. These contracts primarily involve pharmaceutical research and development, with a focus on biologics, vaccines, and therapeutics. The company's core capabilities, such as clinical research, drug development, and regulatory affairs, are critical for advancing medical treatments and public health initiatives. The nature of these contracts reveals the company's strategic direction and its commitment to supporting federal agencies in their research and development efforts. The consistent performance and diverse range of services suggest a robust and adaptable business strategy, which is beneficial for the federal government.
Frequently Asked Questions
What does JANSSEN RESEARCH & DEVELOPMENT, LLC do for the federal government?
JANSSEN RESEARCH & DEVELOPMENT, LLC specializes in pharmaceutical research and development, focusing on biologics, vaccines, and therapeutics. The company provides critical services such as clinical research, drug development, and regulatory affairs, which are essential for advancing medical treatments and public health initiatives. Their core capabilities are aligned with the federal government's mission to improve public health and support medical research.
How much taxpayer money does JANSSEN RESEARCH & DEVELOPMENT, LLC receive?
JANSSEN RESEARCH & DEVELOPMENT, LLC has received a total of $509.4 million in federal contracts. The average contract size is $56,599,309, with all contracts being sole-source awards. This significant investment underscores the importance of the company's research and development services to the federal government.
Is JANSSEN RESEARCH & DEVELOPMENT, LLC good value for taxpayer money?
JANSSEN RESEARCH & DEVELOPMENT, LLC provides critical value to taxpayers through its specialized research and development services. The company's focus on biologics, vaccines, and therapeutics is essential for advancing medical treatments and public health initiatives. However, the sole-source nature of their contracts raises concerns about competition and potential cost escalations. The company's consistent performance and diverse range of services suggest a robust and adaptable business strategy, which is beneficial for the federal government.
How does JANSSEN RESEARCH & DEVELOPMENT, LLC win its contracts?
JANSSEN RESEARCH & DEVELOPMENT, LLC primarily wins contracts through sole-source awards, indicating a lack of competition. This suggests that the company's specialized expertise and resources are highly valued by federal agencies. The company's consistent performance and strong relationships with key agencies contribute to its ability to secure significant contracts in the pharmaceutical research sector.
What agencies use JANSSEN RESEARCH & DEVELOPMENT, LLC most?
JANSSEN RESEARCH & DEVELOPMENT, LLC has a high level of dependency on a few key agencies, indicating a concentrated client base. The company's strong relationships with these agencies are crucial for maintaining its federal business. However, this concentration could pose risks if there are changes in agency priorities or funding. The most significant agencies include the Department of Health and Human Services, the Department of Defense, and the National Institutes of Health.
What are the risks of relying on JANSSEN RESEARCH & DEVELOPMENT, LLC?
The risks of relying on JANSSEN RESEARCH & DEVELOPMENT, LLC include the lack of competition in their sole-source contracts, which could lead to higher costs and reduced innovation. The company's high level of dependency on a few key agencies poses dependency risks and could limit its ability to diversify its client base. The absence of recent contracts suggests potential challenges in securing new business, which could impact the company's growth trajectory.
How does JANSSEN RESEARCH & DEVELOPMENT, LLC compare to similar contractors?
JANSSEN RESEARCH & DEVELOPMENT, LLC holds a dominant position in the pharmaceutical research sector, leveraging its extensive expertise and resources to secure contracts. Compared to industry peers, the company's specialized focus and strong relationships with federal agencies give it a competitive edge. However, the lack of competition in their sole-source contracts and high agency concentration pose challenges that other contractors may not face. The company's consistent performance and diverse range of services suggest a robust and adaptable business strategy, which is beneficial for the federal government.
Recent Federal Contracts
Janssen Research & Development, LLC has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS awards $56.6M to Janssen for R&D in Biotechnology, spanning over 7 years. | Department of Health and Human Services | $56.6M | N/A |